EMA Endorses First Immunotherapy Option for Advanced Anal Cancer
- February 5, 2026
The Invisible Battle No One Warned Me About: Developing Thyroid Eye Disease
Artificial Intelligence Advances Eye Disease Diagnosis: Deep Learning Shows Promise in Distinguishing Thyroid Eye Disease from Orbital Myositis
FDA Places Clinical Hold on REGENXBIO’s MPS Gene Therapy Programs After Tumor Case Review
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
The European Medicines Agency had endorsed the first immunotherapy option for advanced anal cancer. Read more here:
patientworthy.com/2026/02/05/ema-endorses-first-immunotherapy-option-for-advanced-anal-cancer/
From our friends@Amyloidosis Foundation #supportgroup𝕎𝕖'𝕣𝕖 𝕙𝕒𝕡𝕡𝕪 𝕥𝕠 𝕒𝕟𝕟𝕠𝕦𝕟𝕔𝕖 𝕠𝕦𝕣 𝕗𝕚𝕣𝕤𝕥 𝕡𝕒𝕥𝕚𝕖𝕟𝕥 𝕤𝕦𝕡𝕡𝕠𝕣𝕥 𝕘𝕣𝕠𝕦𝕡 𝕞𝕖𝕖𝕥𝕚𝕟𝕘 𝕠𝕗 𝟚𝟘𝟚𝟞!
Our speakers will be:
Dr. Muhamed Baljevic, Hematologist and VAMP Provider
Dr. Baljevic will present AL/Light Chain Updates from the American Society of Hematology
Jessie Parker, AL Patient, who will share her personal journey!
𝑫𝒂𝒕𝒆: 𝑭𝒆𝒃𝒓𝒖𝒂𝒓𝒚 𝟐𝟏, 𝟐𝟎𝟐𝟔
𝑻𝒊𝒎𝒆: 𝟏𝟐:𝟎𝟎𝒑𝒎 - 𝟐:𝟎𝟎𝒑𝒎
𝑳𝒐𝒄𝒂𝒕𝒊𝒐𝒏: 𝑫𝒆𝒍 𝑭𝒓𝒊𝒔𝒄𝒐 𝑮𝒓𝒊𝒍𝒍𝒆
𝟏𝟐𝟎𝟏 𝑫𝒆𝒎𝒐𝒏𝒃𝒓𝒆𝒖𝒏 𝑺𝒕.
𝑵𝒂𝒔𝒉𝒗𝒊𝒍𝒍𝒆, 𝑻𝑵 𝟑𝟕𝟐𝟎𝟑
Parking garage entrances are both just before and just after the restaurant entrance-please bring your parking ticket with you to be validated.
Please join us for a very nice lunch, great conversation and information sharing. Please feel friend to bring guests. The Amyloidosis Foundation covers events w/the help of several sponsors, so there is never a cost to attend. And, this is a great way to help spread knowledge on this challenging disease!
RSVP as soon as possible to: Adrienne Molteni at [email protected] or 615-497-1770.
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
